Speaker illustration

Ms Jolien Neefs

Academic Medical Centre, Amsterdam (Netherlands (The))

Member of:

Thoracoscopic AF ablation is a successful treatment for patients with a giant left atrium

Event: ESC Congress 2019

Topic: Rhythm Control, Atrial Fibrillation Surgery

Session: Surgical therapy in arrhythmia


Sinus node dysfunction after thoracoscopic surgical ablation for atrial fibrillation

Event: EHRA 2019

Topic: Rhythm Control, Atrial Fibrillation Surgery

Session: Young EP poster session - Young meets Experienced


Should every patient with atrial fibrillation and CHA2DS2-VASc score of 1 be anticoagulated? A systemic review

Event: ESC Congress 2018

Topic: Stroke in Atrial Fibrillation

Session: Atrial fibrillation - epidemiology


Risk of atrial fibrillation in heart failure with preserved ejection fraction: results from the treatment of cardiac function with an aldosterone antagonist (TOPCAT) Study

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation obesity


Body fat distribution as risk factor of new-onset atrial fibrillation in The European Prospective Investigation Into Cancer and Nutrition in Norfolk Study


Topic: Clinical and epidemiological aspects (Atrial Fibrillation)

Session: Rapid Fire session 8 - Atrial fibrillation and stroke prevention


Mineralocorticoid receptor antagonists as prevention in atrial fibrillation: a systematic review and meta-analysis

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: Clinic, electrocardiogram, laboratory findings cardioversion and drugs in atrial fibrillation


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb